CORMORANT ASSET MANAGEMENT, LP – Verve Therapeutics, Inc. Transaction History
CORMORANT ASSET MANAGEMENT, LP portfolio value:
$20.61M
portfolio value
CORMORANT ASSET MANAGEMENT, LP quarter portfolio value change:
+124.80%
quarter
Verve Therapeutics, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -14.37% | -100.71K shares | 9.90M | $34.35 | 600K |
| Q2 2022 | share | 0.00% | 0 shares | -5.28M | $15.28 | 700.71K | |
| Q1 2022 | share | Decrease | -36.83% | -408.51K shares | -24.90M | $22.82 | 700.71K |
| Q4 2021 | share | Increase | +56.40% | 400K shares | 8.23M | $37.72 | 1.10M |
| Q3 2021 | share | 0.00% | 0 shares | -7.92M | $47 | 709.22K | |
| Q2 2021 | share | Increase | 0.00% | 709.22K shares | 40.59M | $60.25 | 709.22K |